Keywords: Eysuvis; Lacrisert; Restasis; Tyrvaya; Xiidra; adverse effects; dosage; dry eye disease; efficacy; lactation; lifitegrast; loteprednol; ophthalmic cyclosporine; pregnancy; safety; varenicline.